Company Filing History:
Years Active: 2015-2020
Title: Christoph Stark: Innovator in Antibody Therapeutics
Introduction
Christoph Stark is a notable inventor based in Lorrach, Germany. He has made significant contributions to the field of antibody therapeutics, holding a total of 3 patents. His work focuses on developing innovative formulations that enhance the efficacy of therapeutic antibodies.
Latest Patents
Stark's latest patents include the development of anti-BAFFR antibody therapeutic formulations. These formulations are designed as liquid solutions that contain a high concentration of the antibody active ingredient, ensuring effective delivery to patients while minimizing antibody aggregation. The aqueous pharmaceutical composition may incorporate various components, such as sugars, buffering agents, surfactants, and free amino acids, to optimize the therapeutic effect.
Career Highlights
Christoph Stark is currently associated with Novartis AG, a leading global healthcare company. His role involves advancing research and development in antibody therapies, contributing to the company's mission of improving patient outcomes through innovative medical solutions.
Collaborations
Stark collaborates with various professionals in the field, including his coworker Marta Cosenza. Together, they work on enhancing the understanding and application of antibody therapeutics.
Conclusion
Christoph Stark's contributions to the field of antibody therapeutics exemplify the importance of innovation in medicine. His patents and ongoing work at Novartis AG continue to pave the way for advancements in patient care.